✨ Your Portfolio is fetched and updated from zerodha.
Micro Textiles

Trident Texofab Ltd.

TTFL

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹401 Cr.
P/E
135.62

Trident Texofab Ltd.

  • Trident Texofab
  • Nandan Denim
  • Raghuvir Synth.

FAQs on Trident Texofab Ltd. Shareprice

Trident Texofab has given better returns compared to its competitors.
Trident Texofab has grown at ~39.24% over the last 6yrs while peers have grown at a median rate of 28.0%

Yes, Trident Texofab is expensive.
Latest PE of Trident Texofab is 135, while 3 year average PE is 82.02.
Also latest EV/EBITDA of Trident Texofab is 52.19 while 3yr average is 30.21.

View FAQ's On Business

Growth Table

  • Trident Texofab Ltd.
  • Nandan Denim
  • Raghuvir Synth.

Balance Sheet

  • Trident Texofab Ltd.
  • Nandan Denim
  • Raghuvir Synth.

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Trident Texofab Ltd.
  • Nandan Denim
  • Raghuvir Synth.

Cash Flow

  • Trident Texofab Ltd.
  • Nandan Denim
  • Raghuvir Synth.

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Trident Texofab Ltd.
  • Nandan Denim
  • Raghuvir Synth.

Quarterly Results

  • Trident Texofab Ltd.
  • Nandan Denim
  • Raghuvir Synth.

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Trident Texofab Ltd. Financials

Balance sheet of Trident Texofab is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Trident Texofab is increasing.
Latest net debt of Trident Texofab is ₹28.51 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹20.29 Crs.

Yes, profit is increasing.
The profit of Trident Texofab is ₹2.96 Crs for TTM, ₹2.45 Crs for Mar 2025 and ₹1.08 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Trident Texofab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech